| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
UBS analyst Andrea Alfonso maintains Elanco Animal Health (NYSE:ELAN) with a Buy and raises the price target from $25 to $27.
Elanco posts strong Q3 results with 10% sales growth, surpasses forecasts, and raises full-year revenue and earnings guidance f...
025 Fourth Quarter(dollars in millions, except per share amounts) Guidance Revenue $1,085to$1,110Reported Net Loss $(100)to...
Financial GuidanceElanco is updating financial guidance for the full year 2025, summarized in the following table.2025 Full Yea...